IRE1α activation assists NAFLD progression by inducing inflammatory responses through the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasomes, and NF-κB and JNK signaling [83]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.